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Highlights 
 
 First FFC-MRI hardware setup for a clinical field strength of 3 T 
 Iron oxide magnetic nanoparticles proved as suitable FFC-MRI contrast agent  
 Proof-of-principle of delta relaxation enhanced MR imaging at 3 T 
Abstract 
Contrast agents with a strong R1 dispersion have been shown to be effective in generating 
target-specific contrast in MRI. The utilization of this R1 field dependence requires the 
adaptation of a MRI scanner for fast field-cycling (FFC). Here, we present the first 
implementation and validation of FFC-MRI at a clinical field strength of 3 T. A field-cycling 
range of ±100 mT around the nominal B0 field was realized by inserting an additional insert 
coil into an otherwise conventional MRI system. System validation was successfully performed 
with selected iron oxide magnetic nanoparticles and comparison to FFC-NMR relaxometry 
measurements. Furthermore, we show proof-of-principle R1 dispersion imaging and 
demonstrate the capability of generating R1 dispersion contrast at high field with suppressed 
background signal. With the presented ready-to-use hardware setup it is possible to 
investigate MRI contrast agents with a strong R1 dispersion at a field strength of 3 T. 
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1. Introduction 
As the name implies, fast field-cycling magnetic resonance imaging (FFC-MRI) is the 
combination of fast field-cycling nuclear magnetic resonance (FFC-NMR) relaxometry with 
imaging methods of MRI and is based on cycling the B0 field within an imaging sequence [1]. 
This gives access to new types of contrasts arising from the field dependency of the 1H 
relaxation rates R1 and R2, also termed as R1 and R2 nuclear magnetic relaxation dispersion 
(NMRD), respectively. FFC-MRI can be implemented on clinical MRI systems by inserting an 
additional B0 insert coil into an otherwise conventional scanner. This was previously realized 
for a clinical field strength of 1.5 T and is also referred to as delta relaxation enhanced 
magnetic resonance (dreMR) imaging [2–5].  
Alford et al. [2] demonstrated a differentiation between bound and unbound contrast agent 
(CA) using the targetable probe gadofosveset which only exhibits a strong R1 dispersion upon 
binding to serum albumin. This leads to an improved target specificity by exploiting image 
contrast based on the increased dR1/dB0 of the bound CA instead of the absolute difference 
of the relaxation rate at a fixed magnetic field. Therefore, the dreMR image shows only 
contrast arising from the bound CA and supresses contrast from the anatomical background 
as well as from the unbound agent, which has been recently shown by in-vivo experiments 
with mice [6]. Hoelscher et al. [4] extended the dreMR theory to quantitative concentration 
measurements using a correction for finite ramp times during field-cycling and a 
compensation of field-cycling induced eddy current fields by dynamic reference phase 
modulation [7].  
Whereas the R1 dispersion of healthy tissue is large for low magnetic fields, in the range of 
clinical field strengths, the dispersion is inherently weak (e.g. -0.19 s-1T-1  around 1.5 T for 
murine muscle tissue), as recent findings by Araya et al. [6] have emphasized.  Therefore, the 
use of contrast agents exhibiting a strong dependence of R1 upon the magnetic field i.e. a 
steep slope dR1/dB0 in the NMRD profile is favourable to obtain significant R1 dispersion 
contrast. 
Up to now, all suitable CAs for dreMR utilize a preferably steep slope in the NMRD profile. An 
interesting alternative for dreMR imaging at clinical fields could be the exploitation of extrinsic 
contrast agents based on quadrupole relaxation enhancement (QRE). High spin quadrupole 
nuclei (QN) such as 209Bi offer the potential of QRE peaks emerging in the clinical B0 range 
instead of a smooth dispersion [8]. 
The cross-relaxation between water protons and quadrupole nuclei, i.e. nuclei with a spin 
quantum number > 1/2, gives rise to a shortening of the longitudinal proton relaxation time 
T1. This so called quadrupole relaxation enhancement [9–11] offers a high potential for 
designing smart molecular probes for the usage as MRI contrast agents in the context of 
cellular and molecular imaging [8]. So far the effectiveness of QRE for increasing MRI contrast 
has been shown at low magnetic fields for the cross-relaxation between 14N and 1H in protein 
backbones [1,12,13]. However, this effect is entirely unexplored for the design of extrinsic 
contrast agents at clinical field strengths such as 1.5 T or 3 T. QRE based CAs are frequency 
selective as the cross-relaxation can only become effective if the proton Larmor frequency 
matches one of the transition frequencies of the QN [11]. This favourable feature offers the 
possibility to activate and inactivate QRE, and therefore image contrast, by modulating the 
magnetic field. The frequency position of QRE can either be altered by chemical interaction 
with the biological environment allowing for chemically selective contrasts or by shifting of 
the main B0 field of the MRI system itself, namely FFC-MRI. 
The validation and future application of QRE contrast agents at clinical fields requires a 
dedicated MRI system adapted for fast field-cycling. Although there exist a handful of 1.5 T 
systems worldwide, we show, to the best of our knowledge, the first FFC-MRI setup for a field 
strength of 3 T. To this end, the aim of this work is to present important steps for the 
implementation and validation of a small animal FFC-MRI system for 3 T by means of a B0 
insert coil. We describe the specification of our hardware setup and show a rather simple 
approach to overcome imaging artefacts due to random phase fluctuations induced by the 
output noise current of the gradient power amplifier. Furthermore, system validation is 
performed by FFC-NMR relaxometry measurements and proof-of-concept dreMR imaging of 
selected iron oxide magnetic nanoparticles (IOMNP). The final result is a ready-to-use FFC-MRI 
system for a clinical field strength of 3 T with the envisaged aim of exploiting the magnetic 
field dependency of MRI contrast agents in general and to investigate the imaging potential 
of prospective QRE compounds in particular. 
2. Methods 
Hardware setup 
The field-cycling hardware was implemented on a clinical 3 T MRI system (Skyra, Siemens 
Healthineers, Germany) using a custom-built B0 insert coil (Resonance Research Inc., USA). 
The insert coil has a resistance of 63.8 mΩ and an inductance of 1.69 mH. It is driven by a 
gradient power amplifier (IECO, Finland) capable of a maximum continuous output current of 
±150 A (±300 A peak) and a field efficiency of 0.668 mT/A. This allows for an offset field ∆B0 
of ±100 mT within a minimum ramp time of 1 ms. Field inhomogeneities are less than 1 % over 
a diameter of 35 mm in axial direction. Shielded design of the coil reduces the fringe field to 
0.2 mT at the main magnet bore (radius of 35 cm). The insert is placed in the isocenter of the 
main magnet and holds a custom-built transmit/receive 1H birdcage radio frequency (RF) coil 
(MRI.TOOLS GmbH, Germany) with variable tune and match capability. This enables an 
imaging region of 40 mm in axial and 40 mm in longitudinal direction, which is suitable for 
imaging of phantoms and small animals. The ∆B0 pulses are generated with an arbitrary 
waveform generator controlled by an optical trigger signal from the MRI pulse sequence. This 
design ensures that there is no electronic coupling to the main magnet system. 
A basic FFC-MRI pulse sequence consists of a magnetization preparation such as an inversion 
(IR) or a saturation (SR) RF pulse followed by an evolution phase of duration Tevol with applied 
field shift B0 ± ∆B0 and subsequent signal acquisition at the nominal B0 field. The trigger defines 
the timing of the ∆B0 pulse within the pulse sequence synchronizing the B0 insert coil with the 
MRI system. A schematic of the aforementioned timing is illustrated in Figure 1 and thorough 
reviews of pulse sequences can be found in [4,5,14,15]. 
 Figure 1: Schematic of a FFC-MRI pulse sequence with saturation (SR) or inversion (IR) 
magnetization preparation. The trigger (TRIG) synchronizes the B0 insert coil with the MRI 
system. The ENABLE signal is used for blanking the GPA during image readout to prevent 
imaging artefacts due to random phase fluctuations. The timing of the ∆B0 pulse is as follows: 
delay time after the preparation phase td1, ramp up and ramp down times tru and trd, 
respectively, flat top time tevol and settling time td2. Tevol denotes the total time between 
magnetization preparation and image acquisition.  
Whereas magnetic field inhomogeneities in the order of 1 % during the evolution phase are 
not critical for FFC-MRI, the field stability during signal acquisition is crucial to prevent phase 
errors. In our case the output noise current of the gradient power amplifier (GPA) in the idle 
state induces random phase fluctuations during image acquisition causing serious ghosting 
artefacts in phase encoding direction. This problem has also been observed in other FFC-MRI 
systems [5,16,17]. Recently, a post-processing correction technique was proposed minimizing 
the background signal by determining the optimum phase correction for each line in k-space 
[17]. Another hardware based approach is to alternate the amplifier load between the B0 
insert coil and an inductance-matched dummy load using a fast high-power solid state switch 
[5]. 
Here, we choose an approach utilizing an additional synchronized TTL signal to the dedicated 
control input of the GPA. The GPA is only enabled during the evolution phase and disabled 
throughout image acquisition (see ENABLE signal in Figure 1) so as to suppress the  output 
noise current sufficiently. There is, however, a timing restriction in the hardware of the GPA: 
According to the specifications there is a delay between the edges of the control signal for 
enable and disable and the physical response of the GPA output stage, i.e. about 20 ms 
(enable) and 2 ms (disable), respectively. Consequently, the trigger signal has to be sent 
earliest 20 ms prior to the rising edge of the actual ∆B0 pulse to ensure a safe operation mode 
of the GPA.  
To show the effectiveness of this approach, images were acquired with and without GPA 
blanking using a modified saturation recovery spin echo (SR-SE) sequence with the following 
parameters: repetition time TR = 1000 ms, echo time TE = 15 ms, Tevol = 150 ms, field of view 
FOV = 50 mm x 50 mm, matrix size 256 x 256, bandwidth BW = 130 Hz/Px, flip angle = 90° and 
slice thickness = 5 mm. No field shift was applied for these measurements. 
Eddy current characterization and compensation  
Eddy current related artefacts are a key challenge for FFC-MRI [5,7], in particular, when two 
images with contrast from different B0 field shifts are subtracted. Thus, the characterization 
and compensation of the spurious signal dynamics induced by the eddy current field is crucial. 
Fast ramping of the offset field induces eddy currents in the main magnet structure of the MRI 
system. Though the B0 insert coil is actively shielded to reduce the coupling to the main 
magnet system, the residual fringe field results in a temporally varying offset of the Larmor 
frequency. This offset gives rise to a rigid-body image shift in frequency and slice encoding 
direction. 
The temporal behaviour of the eddy currents (i.e. the Larmor frequency shift) is characterized 
using a modified multi-phase spoiled gradient echo sequence [18]. A phantom holding six 
samples with different concentrations (two-fold serial dilution beginning with 1 mM) of the 
contrast agent Gadovist® (Bayer Vital GmbH, Germany) and a water reference sample was 
prepared. After an applied ∆B0 pulse of +100 mT and Tevol of 300 ms a total number of 50 
images (phases) were acquired with a repetition interval of 17 ms, resulting in a sampling 
duration of 850 ms during the eddy current decay. The remaining imaging parameters were 
as follows: TE = 8.5ms, FOV = 50 mm x 50 mm, matrix size = 64 x 64, BW = 100 Hz/Px, flip 
angle = 15° and slice thickness = 5 mm. The ∆B0 was cycled with a repetition time of 3000 ms. 
Mono- and bi-exponential decay curves were fitted to the obtained frequency shift resulting 
in an accurate model of the eddy current decay. 
During the acquisition of FFC-MRI images, eddy currents then are compensated by dynamic 
reference phase modulation (eDREAM) as proposed in [7]. This method can be directly 
implemented into the MRI pulse sequence and does not require any additional hardware 
adaptations. To validate the eDREAM implementation a reference image (without applied 
field shift) and an image at shifted B0 (∆B0 of +100 mT and Tevol of 300 ms) of the 
aforementioned Gadovist® phantom were acquired, respectively, using a modified SR-SE 
sequence with parameters: TR/TE = 3000/15 ms, FOV = 50 mm x 50 mm, matrix size = 256 x 
256, BW = 130 Hz/Px, flip angle = 90° and slice thickness = 5mm. The shifted image was 
normalized to account for the different equilibrium magnetizations [4] and the difference 
image was obtained by magnitude subtraction of the reference image and shifted image. 
Dispersive contrast agent for 3 T and FFC measurements 
In order to validate the implementation of the FFC-MRI hardware setup, the availability of a 
contrast agent exhibiting strong R1 relaxation dispersion at 3 T is crucial. Recently published 
iron oxide magnetic nanoparticles [19] were selected for system validation because of a 
suspected R1 dispersion at 3 T. Such IOMNPs are obtained by a high temperature surfactant-
assisted chemical route which leads to size- and shape- controlled nanocrystals. IOMNPs with 
similar average size (nearly 8 nm) and with different shapes (spherical and cubical) were used 
dispersed in hexane, and will be referred to as S8_hex and C8_hex, respectively. Samples 
containing three different concentrations (1 mM, 0.5 mM and 0.25 mM) for each shape and a 
hexane reference were prepared and arranged as illustrated in Figure 6a. The samples were 
investigated by Transmission electron microscopy (TEM) on an H-7000 Microscope (Hitachi, 
Japan) equipped with a W gun operating at 125 kV. Fe concentration in the dispersion was 
assessed by quantitative analysis through inductively coupled plasma atomic emission 
spectrometry using a Varian Liberty 200 ICP-AES (Agilent Technologies, USA).  
1H R1 NMRD measurements were performed for the 1 mM samples and the hexane reference 
sample by using a Spinmaster FFC  1 T relaxometer (Stelar, Italy) for a Larmor frequency range 
of 10 kHz-30 MHz. An external HTC-110 3 T superconducting magnet equipped with a 
standalone PC-NMR console (Stelar, Italy) was used for a frequency range of 40 MHz-128 MHz. 
For measurements between 10 kHz-40 MHz one-pulse FFC sequences were used: Below 
10 MHz the sample is pre-polarized at a field of 0.57 T and then the magnetic field is cycled to 
a different value, where the spin system is allowed to relax for a variable time period. Finally, 
the field is cycled back to the detection value, where the FID is recorded following the 
application of a 90° RF pulse. Above 10 MHz, where the signal is reasonably higher than at low 
field, the same procedure was followed except pre-polarization was omitted. For 
measurements between 40-128 MHz a standard inversion recovery sequence was used. 
Furthermore, additional points were measured at 119 MHz, 123.2 MHz and 127.4 MHz 
corresponding to the achievable field cycling range (2.89 T ± 100 mT) of the B0 insert coil. 
Images were acquired with the FFC-MRI system at three different field strengths (2.79 T, 
2.89 T and 2.99 T) and various evolution times (Tevol = 60, 100, 150, 300, 500, 800, 1500 and 
3000 ms) using a modified SR-SE sequence. The remaining imaging parameters were: TR/TE = 
10000/15 ms, FOV = 40 mm x 40 mm, matrix size = 64 x 64, BW = 130 Hz/Px, flip angle = 90° 
and slice thickness = 5 mm. For each field strength, R1 maps were estimated on a pixel-by-
pixel basis by nonlinear fitting to a mono-exponential saturation recovery model [20]. In 
addition, a ∆R1/∆B0 map was calculated by subtracting R1 maps obtained for 2.99 T and 2.79 T.  
DreMR signal simulation 
In general, the behaviour of the magnetization in presence of an external magnetic field can 
be described by the Bloch equations. In the case of field-cycling, the main magnetic field B0 is 
modulated throughout the pulse sequence and thus is a function of time. As the equilibrium 
magnetization M0 and the longitudinal relaxation rate R1 depend on B0, they exhibit also a 
time-dependent behaviour requiring a numerical solver for the Bloch equations. However, 
under several assumptions for the waveform of the ∆B0 pulse, closed-form solutions exist for 
the longitudinal magnetization Mz [12,15]. To predict the behaviour of Mz as a function of the 
evolution time and for different field shifts we slightly adapted the proposed equation in [15] 
for saturation recovery and an additional delay time before the applied field shift. The 
common used linear ramps can be approximated by a step response with relaxation for half 
of the time at the nominal field and the other half at the desired field shift. The change in M0 
and R1 can be assumed to be linear with respect to ∆B0 within the field-cycling range. This 
gives a full description of the magnetization behaviour Mz± under consideration of the 
underlying timing restrictions in a FFC-MRI pulse sequence: 
 
 𝑀𝑧
±(𝑡𝑒𝑣𝑜𝑙) = 𝑀0  + {𝑀0
± − 𝑀0 − {𝑀0
± − 𝑀0 
+ 𝛼𝑀0 exp [− (
𝑡𝑟𝑢
2
 +  𝑡𝑑1) 𝑅1]} exp [− (𝑡𝑒𝑣𝑜𝑙  +
𝑡𝑟𝑢 + 𝑡𝑟𝑑
2
) 𝑅1
±]} exp [− (
𝑡𝑟𝑑
2
 + 𝑡𝑑2) 𝑅1] 
(1) 
𝑤ℎ𝑒𝑟𝑒    𝑀0
± = 𝑀0 (1 ±
Δ𝐵0
𝐵0
)  . (2) 
M0 and M0± are the equilibrium magnetizations, R1 and R1± the relaxation rates at nominal and 
shifted B0 field, respectively. The superscript ± indicates whether a positive or negative field 
shift is applied. For saturation recovery the parameter α should be equal to 1, td1 is the delay 
time between saturation pulse and begin of the ramp up time tru, trd is the ramp down time, 
tevol is the flat top time and td2 is the settling time after the ∆B0 pulse. Tevol is given by the total 
time between magnetization preparation and begin of the image acquisition. This timing of 
∆B0 within the pulse sequence is illustrated in Figure 1. Exemplarily, we simulated the 
relaxation curves for a positive and negative field shift of ±100 mT for the sample containing 
0.5 mM of cubic-shaped IOMNPs (ROI 2 in Figure 6a). The estimated R1 values as well as M0 
from the aforementioned measurements were used for the simulation. The timing parameters 
of the ∆B0 used for simulation were as follows: td1 = 9 ms, tru = trd = 1 ms, td2 = 9.78 ms and tevol 
was increased in 0.01 ms steps to span the desired simulation range (up to 3000 ms). In a next 
step, the simulated relaxation curves were compared to the measured curves. All curves were 
normalized to account for different equilibrium magnetizations and effective offset fields as 
proposed in [4]. Furthermore, the difference between Mz+ and Mz- relaxation curves was 
calculated resulting in the corresponding dreMR signal. 
DreMR imaging 
Images at B0+∆B0 (2.99 T) and B0-∆B0 (2.79 T) were acquired to demonstrate the feasibility of 
generating contrast based only on dispersive properties of the contrast agent. The imaging 
parameters of the modified SR-SE sequence were as follows: Tevol = 150 ms, TR/TE = 
3000/15 ms, FOV = 40 mm x 40 mm, matrix size = 192 x 192, BW = 130 Hz/Px, flip angle = 90° 
and slice thickness = 5 mm. In order to maximize the contrast in the dreMR image the 
evolution time Tevol should be chosen to match approximately the sample’s T1 [4]. Again, all 
images were normalized prior to magnitude subtraction obtaining the final dreMR image. 
3. Results and Discussion 
Hardware setup 
Figure 2a shows ghosting artefacts which arose when the GPA was left enabled during image 
acquisition. They appeared only in phase encoding direction due to the random phase 
fluctuations caused by the output current noise of the GPA. The GPA blanking eliminates all 
visible ghosting artefacts and a well-resolved image of the phantom can be obtained (Figure 
2b). In addition to the intrinsic timing restrictions, i.e., 20 ms for enable and 2 ms for disable, 
the GPA noise might interfere with the magnetization preparation module if an overlap with 
the RF pulse occurs. Hence, the beginning of the trigger signal must be timed accordingly to 
prevent such interferences. Figure 3 shows the measured timing between trigger and begin of 
the field-shift including the onset of increased output noise  once the GPA is enabled.  
 
Figure 2: (a) Random phase fluctuations induced by the output current noise of the GPA cause 
severe ghosting artefacts in phase encoding direction. (b) Disabling the GPA during image 
acquisition eliminates all visible artefacts. 
This required delay time was included in equation (1) as td1 to account for a relaxation with B0 
prior the actual begin of the field shift. The GPA blanking approach is rather easy to implement 
as it utilizes the available control input of the GPA and requires only one additional TTL signal. 
Of course, the implementation is restricted to amplifiers providing such a dedicated control 
input and sufficient short enable and disable times. The inherent timing delays can be 
considered during the design and programming of the FFC-MRI pulse sequence and are not a 
limiting factor for the FFC-MRI sequences discussed here as the TR is usually much longer than 
the enable time. However, for other types of sequences, e.g. with very short repetition times, 
i.e. in the range of the enable time (i.e. 20 ms), other correction methods like in [5,17] must 
be used.  
 
Figure 3: Measured timing of the TTL trigger signal (CH1, lower trace) and the voltage 
proportional to the output current of the GPA (CH2, upper trace). The rising edge of the B0 
waveform (3) occurs 24.5 ms after the end of the trigger pulse (1). The cursors indicate the 
interval (2) between GPA enable and the rising B0 edge. The increased noise level in this phase 
is clearly visible and has a duration of ∆t = 7.60 ms. 
The imaging region of the presented B0 insert coil is limited to phantom and small animal 
applications. Significant effort has gone into the construction of a fully commissioned human-
scale FFC-MRI system with a maximum field strength of 0.2 T [21]. The inherently present R1 
dispersion in this field cycling range may have applications in the early diagnosis of a range of 
disease [22,23]. For dreMR imaging there exist feasibility studies of B0 insert coils designed for 
human head and prostate imaging [24,25], which is an important step towards clinical 
applications at high field.  
Eddy current characterization and compensation 
The measured frequency shift induced by the eddy currents after a positive ∆B0 pulse is shown 
in Figure 4a for an amplitude of 100 mT, ramp times of 1ms and an evolution time of 300 ms. 
Fitting of a mono-exponential model resulted in a model amplitude of 367.6 Hz and a time 
constant of 169.3 ms with 95% confidence intervals (CI) of [359.4 Hz, 375.8 Hz] and [164.2 ms, 
174.9 ms], respectively. Fitting of a bi-exponential model resulted in a slow and fast decaying 
component with amplitudes of 336.2 Hz and 97.6 Hz and with time constants of 183.6 ms and 
17.8 ms, respectively. The CIs were [331.0 Hz, 341.5 Hz] and [87.5 Hz, 107.8 Hz] for the 
amplitudes and [180.9 ms, 186.4 ms] and [14.8 ms, 22.4 ms] for the time constants, 
respectively. The bi-exponential model with an adjusted R2 value of 0.9996 performs better 
than the mono-exponential model with an adjusted R2 value of 0.9951. The better fit can be 
seen notably at the beginning of the eddy current decay curve in Figure 4a, i.e. in the time 
interval where the eddy current characterization is crucial for the eDREAM compensation. 
Given this more accurate description in the beginning of the eddy current decay the bi-
exponential model was used for the eDREAM implementation. The uncompensated eddy 
current effects lead to a rigid-body image shift in frequency and slice encoding direction 
causing severe artefacts when calculating the difference between reference image and shifted 
image (Figure 4b). The eddy current artefacts are completely removed by using the eDREAM 
compensation with the bi-exponential model (Figure 4c). As Gadovist® (Bayer Vital GmbH, 
Germany) has a negligible magnetic field dependence [26] in the achievable B0 field-cycling 
range, no significant signal is expected in the difference image. 
It is important to note that the dynamics of the eddy current field depend on several 
parameters of the ∆B0 pulse such as amplitude, ramp up time, flat top time, ramp down time 
and repetition time. The results presented herein are exemplary for a field shift of 100 mT, 
equal ramp times of 1ms each, a Tevol of 300 ms and a TR of 3000 ms. For different timing 
parameters a new characterization becomes necessary. It is to be expected that increasing the 
ramp times would lead to a decrease of the frequency shift due to a smaller dB/dt and hence 
lower eddy currents. Furthermore, a TR of 3000 ms is long enough (> 5 time constants) to 
allow for a sufficient eddy current decay before applying the next ∆B0 pulse as can be seen in 
Figure 4a where the measured frequency shift has decayed  below 3 Hz after 900 ms. Short 
TRs (< 5 time constants) lead to a formation of a dynamic steady state as the eddy current 
fields of the previous ∆B0 pulse add to the field induced by the next ∆B0 pulse. A 
comprehensive analysis of eddy current formation and the eDREAM compensation has been 
given by Hoelscher et al. in [7].   
 
  
Figure 4: (a) Measured frequency shift induced by the eddy currents (blue circles) for a 100 mT 
∆B0 pulse with Tevol of 300 ms and a ramp times of 1ms. A mono-exponential (green line) as 
well as a bi-exponential (red line) model were fitted to the data. This characterization of the 
eddy current field dynamics allows for a compensation by means of dynamic reference phase 
modulation. (b) Difference between reference image and image at shifted B0 without eddy 
current compensation and (c) with compensation using the bi-exponential model. 
Dispersive contrast agent for 3T and FFC measurements 
Both the cube-shaped as well as the spherically shaped IOMNPs proved to be suitable for 
system validation at a field strength of 3 T as they exhibit a pronounced peak in the NMRD 
profile (Figure 5) around 20 MHz followed by a steep downward slope in the targeted 
frequency range of 119-127.4 MHz corresponding to 2.89T±100 mT. In contrast, the hexane 
sample shows only a weak dependence on the magnetic field i.e. a flat slope in the NMRD 
profile within the achievable field-cycling range and is therefore suited as a non-dispersive 
reference. 
Furthermore, for visual comparison of all samples, R1 maps for 2.79 T and 2.99 T together with 
the corresponding R1 dispersion map are shown in Figure 6b-d, respectively. The spherical 
IOMNPs (C8_hex) show higher R1 values and a steeper slope of the NMRD profile (Figure 5) in 
comparison to the cubic IOMNPs (S8_hex). This is also emphasized by the R1 dispersion map 
in Figure 6d, giving a good linear approximation of the slope in the NMRD profile within the 
achievable field-cycling range i.e. ∆R1/∆B0. As expected, no significant ∆R1/∆B0 is visible in the 
R1 dispersion map for the hexane reference sample.  
 
Figure 5: 1H R1 NMRD profiles of the cubic (C8_hex, red squares) and spherical (S8_hex, blue 
circles) IOMNPs with 1 mM concentration as well as of pure hexane (ref, yellow triangles) 
measured up to a field strength of 3 T (127.8 MHz) using a commercial FFC-NMR relaxometer. 
All measurements were performed at room temperature (295 K). The insets show 
representative TEM images of S8 and C8 samples, indicating that the used IOMNPs have 
different morphology and are nearly monodisperse in size and shape. 
Table 1 compares the R1 values obtained with FFC-MRI measurements and the corresponding 
data points in the NMRD profile (2.79 T, 2.89 T and 2.99 T) for C8_hex and S8_hex IOMNPs 
samples with 1 mM concentration. In order to exclude pixels at the edges from the evaluation, 
the R1 values have been estimated over a rectangular ROI in the middle of sample 1 and 4 in 
Figure 6a. The R1 estimation with the proposed FFC-MRI system is in accordance with the FFC-
NMR measurements (Stelar, Spinmaster). Compared to the FFC-NMR measurements, the R1 
values obtained with FFC-MRI are slightly lower for the S8_hex samples and slightly higher for 
the C8_hex samples with mean relative errors of -11.6 % and +7.6 %, respectively. It is likely 
that this systematic error results from different sample concentrations due to inaccuracies in 
the sample preparation and possible sample degradation during delivery to the FFC-NMR 
facility. Regardless of this error, the agreement between FFC-MRI and FFC-NMR 
measurements is sufficient for system validation. 
All used IOMNPs were dispersed in hexane as they are produced by a synthetic route which 
leads to hydrophobic nanocrystals with high crystallinity and highest size and shape control 
achievable to date. The inset in Figure 5 reports representative TEM images of the C8 and S8 
IOMNPs, showing that both samples are nearly monodisperse in size and shape. The use of 
the IOMNPs dispersed in an organic solvent is therefore justified for the validation of the 
proposed FFC-MRI system, because the signal-to-noise ratio (SNR) is important for an accurate 
characterization. Theoretically, it is possible to dissolve them in an aqueous solution, but this 
comes at the expense of losing R1 dispersion [19]. The development of strategies for the 
dispersion in water without losing the beneficial relaxometric properties and achievable SNR, 
should be investigated in a separate study to enable direct applicability of the IOMNPs to in-
vivo experiments. 
 
Figure 6: (a) Sample arrangement in the phantom containing three different concentrations 
of cubic (C8_hex) and spherical (S8_hex) IOMNPs as well as a non-dispersive hexane reference 
sample (ref). (b) and (c) show R1 maps calculated on a pixel-by-pixel basis for a field strength 
of 2.79T and 2.99T, respectively. (d) R1 dispersion map ∆R1/∆B0 (magnitude) obtained from (b) 
and (c). 
Table 1: Comparison of R1 at different field strengths measured with a commercial FFC-NMR 
relaxometer and with the proposed FFC-MRI system (mean ± standard deviation). For the FFC-
MRI method, R1 values were obtained by ROI analysis (rectangular ROI in the middle of each 
sample).  
Sample Method 
Longitudinal relaxation rates (s-1) 
2.79T 2.89T 2.99T 
S8_hex 
(1mM) 
FFC-NMR 13.62 (±0.14) 13.17 (±0.13) 12.77 (±0.13) 
FFC-MRI 12.21 (±0.31) 11.63 (±0.34) 11.14 (±0.35) 
C8_hex 
(1mM) 
FFC-NMR 6.25 (±0.06) 6.07 (±0.06) 5.93 (±0.06) 
FFC-MRI 6.81 (±0.13) 6.54 (±0.14) 6.29 (±0.13) 
 
DreMR signal simulation 
The behaviour of the longitudinal magnetization Mz in the presence of a trapezoidal field shift 
applied during the evolution phase was simulated using equation (1). Simulated relaxation 
curves (normalized to M0) for a positive and negative field shift of 100 mT are shown in Figure 
7a and compared to FFC-MRI measurement data for various evolution times (Tevol = 60, 100, 
150, 300, 500, 800, 1500 and 3000 ms). The measured relaxation curves show a high degree 
of congruence with the simulation, which accounts for all underlying timing restrictions in the 
∆B0 pulse. The applied field shifts of ±100mT result in a relaxation to different equilibrium 
magnetizations of M0±=M0±3.3%. Theoretically, a relaxation to M0±=M0 ±3.46% (M0(1±∆B0/B0)) 
is expected for a rectangular field shift without timing restrictions such as finite ramp times 
and delay times td1 and td2. In order to isolate only the effect of R1 dispersion in the dreMR 
signal a proper field-dependent scaling is of great importance as discussed by Hoelscher et al. 
in references [4,27]. Figure 7b shows the characteristic dreMR signal (magnitude) obtained 
after subtraction of the relaxation curves for 2.79 T and 2.99T. Prior to subtraction the 
relaxation curves were normalized to account for relaxation to different M0 and effective 
offset fields. The measured data is in good agreement with the dreMR signal simulation after 
accounting for all timing restrictions. Furthermore, we observe a minimum (for negative 
∆R1/∆B0) located around the T1 of the sample (ROI 2) which is approximately 267 ms. As dreMR 
images are based on image subtraction they suffer from a poor SNR. In order to maximize the 
dreMR contrast for a specific sample the evolution time Tevol should be chosen to match the 
sample’s T1 [4]. Therefore, equation (1) can be used to optimize dreMR imaging parameters 
under consideration of all timing restrictions of the ∆B0 pulse in the MRI pulse sequence. 
 
Figure 7: (a) Simulated longitudinal relaxation curves for 2.99 T (red solid line) and 2.79 T (blue 
dashed line) compared to relaxation curves measured (mean ± standard deviation of ROI 2 in 
Figure 6a) with the proposed FFC-MRI system (upward-pointing triangle for 2.99 T and 
downward-pointing triangle for 2.79T). (b) Simulated and measured dreMR signal obtained by 
subtraction of the relaxation curves in (a) after normalization to account for different 
equilibrium magnetizations and effective ∆B0 offset fields. 
DreMR imaging 
Figure 8 shows a dreMR image acquired with a Tevol of 150 ms and an isotropic in-plane 
resolution of 0.2 mm. As can be clearly seen, signal arises only from samples containing the 
dispersive IOMNPs, whereas the signal is strongly suppressed in the hexane reference sample. 
When comparing samples containing cubic shaped IOMNPS (samples 1-3 in Figure 6a), 
theoretically, maximum signal intensity should be observed for sample 1 as Tevol ≈ T1. In 
practice, the dreMR contrast in Figure 8 is altered by an additional T2-weighting due to short 
T2 of the IOMNPs [19]. Consequently, the samples with the highest concentrations seemingly 
paradoxically, show less contrast enhancement, though, in reality, their T1 enhancement is 
maximal. Nevertheless, this dreMR image is a clear proof-of-principle, demonstrating the 
capability of generating R1 dispersion contrast with suppressed background signal at a clinical 
field strength of 3 T. This proof is sufficient for the purpose of system validation only. For 
improved evaluation of signal contrasts, the TE of 15 ms has to be reduced to the order of a 
few ms to minimize the T2-weighting, which was not feasible with the modified SR-SE 
sequence used herein. 
Theoretically, a twofold increase in SNR of the images prior dreMR image subtraction is to be 
expected for 3 T compared to 1.5 T [28]. Aside from this potential benefit, the SNR increase in 
the dreMR image may be compensated by a reduced R1 dispersion at 3 T. Whether a field 
strength of 1.5 T or 3 T is more beneficial for dreMR imaging depends strongly on the NMRD 
profile of the contrast agent in use. In the context of prospective QRE based contrast agents, 
it is favourable to have a wide variety of field-cycling ranges as it is completely unexplored at 
which field strength such compounds give the best image contrast. Therefore, the presented 
FFC-MRI system expands the field cycling technique with an additional cycling range centered 
at 2.89 T.    
 
Figure 8: Images acquired for a field strength of 2.99 T (a) and 2.79 T (b) with an isotropic in-
plane resolution of 0.2 mm and Tevol of 150 ms were normalized to account for different M0 
and effective offset fields. Image subtraction of (a) and (b) resulted in the corresponding 
dreMR image whereof the magnitude is shown in (c). 
 
4. Conclusions 
In conclusion, we have successfully implemented a small animal FFC-MRI system for a clinical 
field strength of 3 T by inserting an additional B0 insert coil into an otherwise conventional 
MRI system. Iron oxide magnetic nanoparticles proofed to be suitable for system validation as 
they exhibit a sufficiently high R1 relaxation dispersion in the achievable field-cycling range of 
±100 mT around the nominal field strength of 2.89 T. System validation was successfully 
performed by comparison of FFC-MRI measurements with FFC-NMR relaxometry. 
Furthermore, a proof-of-principle for dreMR imaging at 3 T has been achieved by generating 
contrast arising only from the dispersive properties of the contrast agent in use. In the context 
of developing new contrast agents, this hardware implementation and validation provides a 
ready-to-use hardware setup for investigating dispersive properties of MRI contrast agents at 
a field strength of 3 T.  
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